Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer

HER new potential: New advances in HER2+ breast cancer treatment

Date

22 Sep 2020

Session

AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer

Presenters

Erika Hamilton

Authors

E.P. Hamilton

Author affiliations

  • Drug Development Unit, Sarah Cannon Research Institute-Cancer Centre, 37203 - Nashville/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings